CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 326-350 of 794 matching filings.

Per page
25
Current page
14
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Jun 2021
Reporting date
14 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2021
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2021
Reporting date
31 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2021
Reporting date
31 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-255832

S-8

Filing date
06 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-37587

10-Q - Q1/2021

Filing date
06 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
8-K File 001-37587

8-K-050621 Q1-21 EARNINGS

Filing date
06 May 2021
Reporting date
06 May 2021
Next action
Verify source filing
SC 13G/A File 005-89140

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Filing date
03 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37587

DEFA14A

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37587

DEF 14A

Filing date
28 Apr 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Apr 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
05 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .